145 related articles for article (PubMed ID: 11932879)
1. Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
Marchesoni A; Battafarano N; Arreghini M; Pellerito R; Cagnoli M; Prudente P; Cerase A; Priolo F; Tosi S
Arthritis Rheum; 2002 Feb; 47(1):59-66. PubMed ID: 11932879
[TBL] [Abstract][Full Text] [Related]
2. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
Marchesoni A; Battafarano N; Arreghini M; Panni B; Gallazzi M; Tosi S
Rheumatology (Oxford); 2003 Dec; 42(12):1545-9. PubMed ID: 12810924
[TBL] [Abstract][Full Text] [Related]
3. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
Sarzi-Puttini P; D'Ingianna E; Fumagalli M; Scarpellini M; Fiorini T; Chérié-Lignière EL; Panni B; Fiorentini F; Corbelli V; Beyene NB; Mastaglio C; Severi C; Locati M; Cazzola M; Menozzi G; Monti G; Saccardo F; Alfieri G; Atzeni F
Rheumatol Int; 2005 Jan; 25(1):15-22. PubMed ID: 14530867
[TBL] [Abstract][Full Text] [Related]
4. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
5. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S;
Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
Gerards AH; Landewé RB; Prins AP; Bruyn GA; Goei Thé HS; Laan RF; Dijkmans BA
Ann Rheum Dis; 2003 Apr; 62(4):291-6. PubMed ID: 12634224
[TBL] [Abstract][Full Text] [Related]
7. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
Stein CM; Pincus T; Yocum D; Tugwell P; Wells G; Gluck O; Kraag G; Torley H; Tesser J; McKendry R; Brooks RH
Arthritis Rheum; 1997 Oct; 40(10):1843-51. PubMed ID: 9336420
[TBL] [Abstract][Full Text] [Related]
9. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
Ferraccioli GF; Gremese E; Tomietto P; Favret G; Damato R; Di Poi E
Rheumatology (Oxford); 2002 Aug; 41(8):892-8. PubMed ID: 12154206
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
Odderskov C; Stengaard-Pedersen K; Ellingsen T; Hornung N
Scand J Clin Lab Invest; 2020 May; 80(3):185-190. PubMed ID: 31876200
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
12. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
Smolen JS; Wollenhaupt J; Gomez-Reino JJ; Grassi W; Gaillez C; Poncet C; Le Bars M; Westhovens R
Arthritis Res Ther; 2015 Jun; 17(1):157. PubMed ID: 26063454
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination].
Danieli MG; Fratini M; Rossetti L; Giovagnoni A; Amici F; Danieli G
Recenti Prog Med; 1998 Jan; 89(1):7-13. PubMed ID: 9549386
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
15. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial.
Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante EJ; Churchill M; Park W; Pons-Estel B; Han C; Gathany TA; Xu S; Zhou Y; Leu JH; Hsia EC
Arthritis Care Res (Hoboken); 2016 Jun; 68(6):744-52. PubMed ID: 26474452
[TBL] [Abstract][Full Text] [Related]
17. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
Gaujoux-Viala C; Rincheval N; Dougados M; Combe B; Fautrel B
Ann Rheum Dis; 2017 Dec; 76(12):2054-2060. PubMed ID: 28866645
[TBL] [Abstract][Full Text] [Related]
18. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
Verschueren P; Esselens G; Westhovens R
Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group.
Fleischmann R; Mease PJ; Schwartzman S; Hwang LJ; Soma K; Connell CA; Takiya L; Bananis E
Clin Rheumatol; 2017 Jan; 36(1):15-24. PubMed ID: 27734232
[TBL] [Abstract][Full Text] [Related]
20. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
Keystone EC; Haraoui B; Guérette B; Mozaffarian N; Liu S; Kavanaugh A
J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
